ALDURAZYME: payments to doctors
Payments that named ALDURAZYME as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $464K
- Providers
- 565
- Transactions
- 847
- Average per transaction
- $548
The per-transaction average — $548 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 565 providers the average total is $821, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sanofi | $364,511 | 78.5% |
| Sanofi-aventis U.S. LLC | $99,594 | 21.5% |